Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-390506

Co-Chief Executive Officer sold 30,464 shares at an average $32.18 ($980,263)

From the SEC's structured data for this filing

Trades in this filing

Klee Justin B. · Co-Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-10 Sale : show line 1 in the form −29,025 $32.13 $932,553 3,614,495 D
2026-09-10 Sale : show line 2 in the form −1,439 $33.16 $47,710 3,613,056 D
Open-market sales · 30,464 sh · avg $32.18 · $980,263
Loading xslF345X06/ownership.xml…